1. European Monitoring Centre for Drugs and Drug Addiction EMCDDA Perspectives on Drugs Synthetic Cannabinoids in Europe 2017.http://www.emcdda.europa.eu/publications/pods/synthetic‐cannabinoids_en.Accessed September 27 2018.
2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).Risk assessment report on a new psychoactive substance Methyl 2‐{[1‐(5‐fluoropentyl)‐1H‐indazole‐3‐carbonyl]amino}‐3 3‐ dimethylbutanoate. Lisbon Portugal 2017.https://doi.org/10.2810/210307
3. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues
4. World Health Organization (WHO). 5F‐ADB. Critical Review Report. Agenda Item 4.2. Expert Committee on Drug Dependence. Thirty‐ninth Meeting. Geneva Switzerland: 2017.http://www.who.int/medicines/access/controlled‐substances/CriticalReview_5F‐ADB.pdfAccessed November 20 2018
5. Identification and quantitation of 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, in the stomach contents and solid tissues of a human cadaver and in some herbal products